Recombinant multi-species RPS6KA1/RSK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPS6KA1/RSK1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the RSK (ribosomal S6 kinase) family of serine/threonine kinases. This kinase contains 2 nonidentical kinase catalytic domains and phosphorylates various substrates, including members of the mitogen-activated kinase (MAPK) signalling pathway. The activity of this protein has been implicated in controlling cell growth and differentiation. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 90 kDa ribosomal protein S6 kinase 1 (p90-RSK 1,HU-1,MAP kinase-activated protein kinase 1a (MAPK-activated protein kinase 1a,MAPKAP kinase 1a,MAPKAPK-1a),MAPKAPK1,MAPKAPK1A,Mapkapk-1a,RPS6KA1,RSK,RSK1,Ribosomal S6 kinase 1 (RSK-1),Ribosomal protein S6 kinase alpha-1,Rps6ka1,Rsk,Rsk-1,Rsk1,S6K-alpha 1,S6K-alpha-1,p90-Rsk1,p90RSK1,p90Rsk,p90Rsk1,p90S6K,p90S6K),p90rsk

Target products collectionGo to RPS6KA1/RSK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T83202-Ag-1/ GM-Tg-hg-T83202-Ag-2 Human RPS6KA1/RSK1 protein Human
GM-Tg-rg-T83202-Ag-1/ GM-Tg-rg-T83202-Ag-2 Rat RPS6KA1/RSK1 protein Rat
GM-Tg-mg-T83202-Ag-1/ GM-Tg-mg-T83202-Ag-2 Mouse RPS6KA1/RSK1 protein Mouse
GM-Tg-cynog-T83202-Ag-1/ GM-Tg-cynog-T83202-Ag-2 Cynomolgus/Rhesus macaque RPS6KA1/RSK1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T83202-Ag-1/ GM-Tg-felg-T83202-Ag-2 Feline RPS6KA1/RSK1 protein Feline
GM-Tg-cang-T83202-Ag-1/ GM-Tg-cang-T83202-Ag-2 Canine RPS6KA1/RSK1 protein Canine
GM-Tg-bovg-T83202-Ag-1/ GM-Tg-bovg-T83202-Ag-2 Bovine RPS6KA1/RSK1 protein Bovine
GM-Tg-equg-T83202-Ag-1/ GM-Tg-equg-T83202-Ag-2 Equine RPS6KA1/RSK1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T83202-Ag-1/ GM-Tg-hg-T83202-Ag-2; GM-Tg-rg-T83202-Ag-1/ GM-Tg-rg-T83202-Ag-2;
GM-Tg-mg-T83202-Ag-1/ GM-Tg-mg-T83202-Ag-2; GM-Tg-cynog-T83202-Ag-1/ GM-Tg-cynog-T83202-Ag-2;
GM-Tg-felg-T83202-Ag-1/ GM-Tg-felg-T83202-Ag-2; GM-Tg-cang-T83202-Ag-1/ GM-Tg-cang-T83202-Ag-2;
GM-Tg-bovg-T83202-Ag-1/ GM-Tg-bovg-T83202-Ag-2; GM-Tg-equg-T83202-Ag-1/ GM-Tg-equg-T83202-Ag-2
Products Name RPS6KA1/RSK1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RPS6KA1/RSK1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPS6KA1/RSK1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.